Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soft tissue necrosis in patients treated with transoral robotic surgery and postoperative radiotherapy: preliminary results.
Alterio D, Tagliabue M, Muto M, Zorzi S, Volpe S, Gandini S, Sibio D, Bayır Ö, Marvaso G, Ferrari A, Bruschini R, Cossu Rocca M, Preda L, Marangoni R, Starzynska A, Vigorito S, Ansarin M, Jereczek-Fossa BA. Alterio D, et al. Among authors: marvaso g. Tumori. 2020 Dec;106(6):471-479. doi: 10.1177/0300891619900920. Epub 2020 Jan 30. Tumori. 2020. PMID: 31996091
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.
Timon G, Ciardo D, Bazani A, Garioni M, Maestri D, De Lorenzo D, Pansini F, Cambria R, Rondi E, Cattani F, Marvaso G, Zerini D, Vischioni B, Ciocca M, Russo S, Molinelli S, Golino F, Scroffi V, Rojas DP, Fodor C, Petralia G, Santoro L, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: marvaso g. Tumori. 2016 Oct 13;102(5):536-540. doi: 10.5301/tj.5000547. Epub 2016 Aug 5. Tumori. 2016. PMID: 27514314 Clinical Trial.
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G, Jereczek-Fossa BA, Vischioni B, Ciardo D, Giandini T, Hasegawa A, Cattani F, Carrara M, Ciocca M, Bedini N, Villa S, Morlino S, Russo S, Zerini D, Colangione SP, Panaino CMV, Fodor C, Santoro L, Pignoli E, Valvo F, Valdagni R, De Cobelli O, Orecchia R. Marvaso G, et al. Tumori. 2017 May 12;103(3):314-318. doi: 10.5301/tj.5000587. Epub 2016 Dec 2. Tumori. 2017. PMID: 28009421 Clinical Trial.
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.
Jereczek-Fossa BA, Fanetti G, Fodor C, Ciardo D, Santoro L, Francia CM, Muto M, Surgo A, Zerini D, Marvaso G, Timon G, Romanelli P, Rondi E, Comi S, Cattani F, Golino F, Mazza S, Matei DV, Ferro M, Musi G, Nolè F, de Cobelli O, Ost P, Orecchia R. Jereczek-Fossa BA, et al. Among authors: marvaso g. Clin Genitourin Cancer. 2017 Aug;15(4):e623-e632. doi: 10.1016/j.clgc.2017.01.004. Epub 2017 Jan 11. Clin Genitourin Cancer. 2017. PMID: 28185875
Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.
Alterio D, Cossu Rocca M, Russell-Edu W, Dicuonzo S, Fanetti G, Marvaso G, Preda L, Zorzi S, Verri E, Nole' F, Jereczek-Fossa BA. Alterio D, et al. Among authors: marvaso g. Med Oncol. 2017 May;34(5):86. doi: 10.1007/s12032-017-0952-z. Epub 2017 Apr 8. Med Oncol. 2017. PMID: 28391578 Review.
Interim 18FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic review.
Ferrari M, Travaini LL, Ciardo D, Garibaldi C, Gilardi L, Glynne-Jones R, Grana CM, Jereczek-Fossa BA, Marvaso G, Ronchi S, Leonardi MC, Orecchia R, Cremonesi M. Ferrari M, et al. Among authors: marvaso g. Crit Rev Oncol Hematol. 2017 May;113:28-42. doi: 10.1016/j.critrevonc.2017.02.019. Epub 2017 Feb 20. Crit Rev Oncol Hematol. 2017. PMID: 28427517 Review.
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D, Marvaso G, Maffini F, Gandini S, Chiocca S, Ferrari A, Preda L, Rocca MC, Lepanto D, Fodor C, Volpe S, Dicuonzo S, Laudati A, Giugliano G, Ansarin M, Jereczek-Fossa BA. Alterio D, et al. Among authors: marvaso g. Med Oncol. 2017 Jun;34(6):107. doi: 10.1007/s12032-017-0965-7. Epub 2017 Apr 27. Med Oncol. 2017. PMID: 28452036
147 results